Search results for "rectum"

showing 10 items of 172 documents

Extraprostatic Spindle Cell Stromal Tumor of the Prostate: Case Report

2007

Several benign and malignant nonepithelial and stromal-like lesions arise in the prostate. Because such lesions are rare, their recognition is essential, because treatment and prognosis depend on an adequate pathohistologic classification. We report a case of an 83-year-old man with a stromal tumor of the prostate of uncertain malignant potential (STUMP). He presented with urinary retention and rectal constipation. On bimanual examination, a rectally and suprapubically palpable mass was found. Imaging studies revealed a 12 x 8 cm pararectal inhomogeneous mass of uncertain origin compressing rectum and urethra. The tumor was resected by a retropubic approach and examined immunohistochemicall…

Aged 80 and overMalePathologymedicine.medical_specialtyConstipationUrinary retentionbusiness.industryUrologyCarcinomaCellProstatic NeoplasmsRectumExtraprostaticUrethramedicine.anatomical_structureProstateAbdominal NeoplasmsmedicineHumansmedicine.symptomStromal tumorbusinessUrology
researchProduct

Usefulness of ileostomy defunctioning stoma after anterior resection of rectum on prevention of anastomotic leakage A retrospective analysis

2016

Anastomotic leakage is one of the major complications occurring after anterior resection of rectum. A defunctioning stoma is usually created routinely or on surgeons' discretion. The aim of this study was to investigate the usefulness of temporary ileostomy to prevent anastomotic leakage comparing the postoperative course of patients with and without defunctioning loop ileostomy.Patients that underwent anterior resection of rectum were recruited. 140 patients were enrolled and divided in two groups: patients without and with defunctioning loop ileostomy. Patients' characteristics and other useful data were recorded. A comparison between the two groups was made. The minimum follow-up was 11 …

Aged 80 and overMaleTime FactorsIleostomyRectal NeoplasmsRectumHumansAnastomotic LeakFemaleMiddle AgedAnterior resection of rectum Ileostomy LeakageAgedRetrospective Studies
researchProduct

Procalcitonin and C-reactive protein as early predictors of anastomotic leak in colorectal surgery: a prospective observational study.

2013

Although the early diagnosis of anastomotic leak is a key point in reducing its clinical consequences, in daily practice, anastomotic leak diagnosis is often late.The aim of this study was to determine whether procalcitonin and C-reactive protein are good predictors of anastomotic leak in colorectal surgery.This is a prospective observational study.This study was conducted by a specialized colorectal multidisciplinary team of a tertiary teaching hospital.A series of 205 consecutive patients who underwent elective colorectal surgery in a specialized unit was prospectively analyzed. The following data were collected: demographic, surgical, ASA class, POSSUM, and morbidity. During the first 5 …

CalcitoninMalemedicine.medical_specialtyLeakColonCalcitonin Gene-Related PeptideAnastomotic LeakAnastomosisSensitivity and SpecificityProcalcitoninColon surgeryPredictive Value of TestsMedicineHumansPostoperative PeriodProspective StudiesProtein PrecursorsProspective cohort studybiologybusiness.industryC-reactive proteinGastroenterologyRectumGeneral MedicineMiddle AgedColorectal surgerySurgeryC-Reactive ProteinEarly DiagnosisROC CurvePredictive value of testsbiology.proteinFemalebusinessBiomarkersDiseases of the colon and rectum
researchProduct

Expression of epithelial antigens EPM-1 and EXO-1 in normal, transitional, inflammatory and neoplastic colorectal mucosa

1993

EPM-1 (a high molecular weight glycoprotein) and EXO-1 (a carbohydrate epitope expressed on polar neutral glycolipids and mucins) are two developmental antigens of normal and neoplastic human epithelia and were characterised by monoclonal antibodies. Their distribution was investigated in normal and pathological human colorectal mucosa. In normal mucosa, EPM-1 and EXO-1 showed characteristic expression patterns. EPM-1 was differentially expressed along the crypt villus axis with maximum at the crypt basis. EXO-1 was present throughout the whole mucosa. The characteristic gradient of EPM-1 expression along the crypt axis in normal mucosa was no longer detectable in benign polyps. Intact grad…

Cancer ResearchPathologymedicine.medical_specialtyColonmedicine.drug_classCryptBiologyMonoclonal antibodyEpitopeGlycolipidCrohn DiseaseAntigenAntigens Neoplasmparasitic diseasesmedicineHumansIntestinal Mucosachemistry.chemical_classificationMembrane GlycoproteinsMucinRectumIntestinal PolypsImmunohistochemistryStainingOncologychemistryAntigens SurfaceColitis UlcerativeColorectal NeoplasmsGlycoproteinEuropean Journal of Cancer
researchProduct

EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum.

2014

Contains fulltext : 137861.pdf (Publisher’s version ) (Closed access) BACKGROUND: Care for patients with colon and rectal cancer has improved in the last 20years; however considerable variation still exists in cancer management and outcome between European countries. Large variation is also apparent between national guidelines and patterns of cancer care in Europe. Therefore, EURECCA, which is the acronym of European Registration of Cancer Care, is aiming at defining core treatment strategies and developing a European audit structure in order to improve the quality of care for all patients with colon and rectal cancer. In December 2012, the first multidisciplinary consensus conference about…

Cancer ResearchQuality Assurance Health CareColorectal cancerCancer development and immune defence Radboud Institute for Molecular Life Sciences [Radboudumc 2]Delphi methodSurgical oncologyFAMILIAL ADENOMATOUS POLYPOSISTumours of the digestive tract Radboud Institute for Molecular Life Sciences [Radboudumc 14]MedicineSHORT-COURSE RADIOTHERAPYRectal cancerQuality assurance; Colon cancer; Rectal cancer; Multidisciplinary teams; Consensus; Delphi method; Audit; Neoadjuvant treatment; Adjuvant treatment; SurgerySettore MED/36 - DIAGNOSTICA PER IMMAGINI E RADIOTERAPIADisease ManagementPHASE-III TRIALRANDOMIZED CONTROLLED-TRIALNeoadjuvant TherapyQuality assuranceColon cancerEuropemedicine.anatomical_structureTreatment OutcomeOncologyTRANSANAL ENDOSCOPIC MICROSURGERYColonic NeoplasmsPractice Guidelines as TopicHYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPYmedicine.medical_specialtyNeoadjuvant treatmentEvidence-based practiceConsensusLYMPH-NODE EVALUATIONDelphi methodRectumAuditSDG 3 - Good Health and Well-beingHumansCIRCUMFERENTIAL RESECTION MARGINddc:610business.industryRectal NeoplasmsTOTAL MESORECTAL EXCISIONCancerLONG-TERM SURVIVALAuditAdjuvant treatmentmedicine.diseaseSurgeryOncology nursingFamily medicineSurgeryMultidisciplinary teamsbusiness
researchProduct

Short- and Long-Term Quality of Life and Bowel Function in Patients With MRI-Defined, High-Risk, Locally Advanced Rectal Cancer Treated With an Inten…

2015

Objective Intensified preoperative treatments have been increasingly investigated in locally advanced rectal cancer (LARC), but limited data are available for the impact of these regimens on quality of life (QoL) and bowel function (BF). We assessed these outcome measures in EXPERT-C, a randomized phase 2 trial of neoadjuvant capecitabine combined with oxaliplatin (CAPOX), followed by chemoradiation therapy (CRT), total mesorectal excision, and adjuvant CAPOX with or without cetuximab in magnetic resonance imaging-defined, high-risk LARC. Methods and Materials QoL was assessed using the European Organization for Research and Treatment of Cancer QLQ-C30 and QLQ-CR29 questionnaires. Bowel inc…

Cancer Researchmedicine.medical_specialtyOrganoplatinum CompoundsColorectal cancerHealth StatusCetuximabAntineoplastic AgentsUrinary incontinenceBowel incontinenceSeverity of Illness Indexlaw.inventionRandomized controlled trialQuality of lifelawSurveys and QuestionnairesInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansFecal incontinenceRadiology Nuclear Medicine and imagingSexual Dysfunctions PsychologicalCapecitabineRadiationRectal Neoplasmsbusiness.industryRectumChemoradiotherapy Adjuvantmedicine.diseaseMagnetic Resonance ImagingTotal mesorectal excisionNeoadjuvant TherapyhumanitiesSurgeryOxaliplatinOncologyChemotherapy AdjuvantQuality of Lifemedicine.symptombusinessFecal IncontinenceChemoradiotherapyInternational Journal of Radiation Oncology*Biology*Physics
researchProduct

Storage Diseases: Diagnostic Position

2013

Storage diseases are metabolic multiorgan conditions, which may be divided into lysosomal and nonlysosomal diseases. Disorders of the lysosomal type require electron microscopy for morphological diagnosis. It is the metabolic substrate that determines involvement of the cell type or organ in the individual storage disease, allowing extracerebral biopsies, for instance, in the neuronal ceroid-lipofuscinoses (NCL). A hierarchy of tissues biopsied for diagnosis can be based on easy accessibility: blood lymphocytes, skin, conjunctiva, rectum, skeletal muscle. Lysosomal diseases are divided into vacuolar and nonvacuolar ones. NCL display variegated ultrastructural patterns. Drugs may induce lyso…

Cell typePathologymedicine.medical_specialtyConjunctivaDrug-Related Side Effects and Adverse Reactionsmedicine.diagnostic_testBiopsyRectumSkeletal muscleDiseaseBiologyPathology and Forensic MedicineLysosomal Storage DiseasesMicroscopy Electronmedicine.anatomical_structureLafora DiseasePredictive Value of TestsStructural BiologyVacuolesImmunologyBiopsymedicineUltrastructureHumansLysosomesUltrastructural Pathology
researchProduct

Solitary Rectal Ulcer

1979

Solitary ulcers of the rectum may be traumatic in origin and caused by thermometers, occasionally by digital removal of a fecal impaction, or by deviate sexual behavior. Solitary rectal ulcers may also be a manifestation of Crohn’s disease. Very rarely, ectopic gastric mucosa is their cause. For the vast majority of solitary rectal ulcers, the explanation remains unknown. Occasionally, the ulcers are accompanied by localized inflammation of the mucosa within the distal segment of the rectum with edema, erythema, and circumscribed whitish flecks in a thickened bowel wall covered by excessive secretions. The changes are found predominantly in the ventral portion of the rectum, and in contrast…

Chronic constipationPathologymedicine.medical_specialtyErythemabusiness.industryRectal UlcerFecal impactionRectummedicine.diseasedigestive system diseasesmedicine.anatomical_structureEdemaDefecationMedicinemedicine.symptombusinessProctitis
researchProduct

Hereditary familial polyposis and Gardner’s syndrome: Contribution of the odontostomatology examination in its diagnosis and a case description

2005

La poliposis adenomatosa familiar (PAF) y su variante fenotípica, el síndrome de Gardner, constituyen una infrecuente patología hereditaria autosómica dominante. Se caracterizan por el desarrollo, generalmente durante la segunda y tercera década de la vida, de múltiples pólipos adenomatosos en el colon y en el recto. Estos pólipos tienen un riesgo elevado de transformación maligna subsiguiente, cosa que suele ocurrir en las décadas tercera y cuarta de la vida. Las manifestaciones fenotípicas de la PAF pueden ser muy variadas. Así, además de los pólipos colorrectales, los individuos afectos pueden presentar manifestaciones extracolónicas, entre las que se destacan: pólipos gastroduodenales, …

Colonmarcadores diagnósticosPolyps (Pathology)Rectum diseasesOdontologíaPoliposis familiar hereditaria:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludMalalties del rectedigestive system diseasesPatologia dentalsíndrome de GardnerUNESCO::CIENCIAS MÉDICASMalalties hereditàriesPòlips (Patologia)osteomasDental pathologyCòlonGenetic diseases
researchProduct

Breakthrough Pain (BTP) in Opioid-Tolerant Cancer Patients: A Pan-European Open-Label Multicentre Study with Fentanyl Buccal Tablet (FBT)

2012

ABSTRACT BTP, a transitory exacerbation of pain that occurs on a background of otherwise controlled persistent pain, is a common problem in cancer patients. FBT is indicated for the treatment of BTP in adults with cancer already receiving maintenance opioid therapy for chronic cancer pain and should be titrated to an effective dose that provides adequate analgesia and minimises undesirable events. In this study, patients entered a screening period and were randomized during an open-label titration period to a starting FBT dose of 100 µg (group A) or 200 µg (group B) to identify the FBT effective dose and then treated in an open-label period (for 8 BTP episodes). Patients' inclusion followed…

Exacerbationbusiness.industryBreakthrough PainRectumBone metastasisHematologymedicine.diseaseEffective dose (pharmacology)Group Bmedicine.anatomical_structureOncologyOpioidAnesthesiaFentanyl Buccal Tabletmedicinebusinessmedicine.drugAnnals of Oncology
researchProduct